Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 964 of 6351
-
New hope for Hard-to-Treat myeloma: drug cocktail shows promise
Disease control OngoingThis phase I/II trial identifies the best dose and side effects of selinexor, and how well it works when given in combination with pomalidomide and dexamethasone with or without carfilzomib in treating patients with multiple myeloma that has come back (relapsed) and does not resp…
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Stomach sleeve without surgery shows promise for fatty liver
Disease control OngoingNon-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. Affecting approximately one-third of the United States (U.S.) population, the prevalence of NAFLD increases to 90% in patients with obesity. In 25% of patients, NAFLD progresses to a mor…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could your own immune cells beat brain cancer? new trial aims to find out
Disease control Recruiting nowThis study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with malignant glioma . Autologous TILs are expanded from tumor resections and infused i.v. into the patient after NMA lymphodepletion treatment with hydroxychloroquine…
Early phase 1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a cheap arthritis pill save limbs and hearts?
Disease control Recruiting nowThe Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral artery disease.
Phase 3 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on hard-to-treat blood cancers in early trial
Disease control OngoingThe purpose of this study is to evaluate the safety and feasibility of huCART19-IL18 cells in patients with relapsed or refractory CD19+ cancers.
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Mind-Controlled exoskeleton reads muscle signals to restore natural walking after stroke
Disease control PausedThe purpose of this study is to develop a real-time controller for exoskeletons using neural information embedded in human musculature. This controller will consist of an online interface that anticipates human movement based on high-density electromyography (HD-EMG) recordings, …
Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New surgery could free ugandan babies from lifelong shunts
Disease control OngoingNeonatal postinfectious hydrocephalus (PIH) is a major public health problem in East Africa.The standard treatment has long been placement of a ventriculoperitoneal shunt (VPS) but these devices require life-long maintenance and nearly all fail multiple times. Endoscopic Third Ve…
Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Milder chemo may make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase II clinical trial studies how well treosulfan, thiotepa, fludarabine, and rabbit anti-thymocyte globulin (rATG) before donor stem cell transplantation works in treating patients with nonmalignant (non-cancerous) diseases. Hematopoietic cell transplantation has been sho…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Low-gluten diet in toddlers may cut celiac risk, study finds
Prevention OngoingCeliac disease shares many features of other autoimmune diseases such as type 1 diabetes. Recently, it was published that higher amounts of gluten intake increased the risk for celiac disease. Optimal amounts of gluten to be introduced during weaning have not yet been established…
Sponsor: Lund University • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo aims to outperform chemo in Tough-to-Treat stomach cancer
Disease control CompletedTo determine if the regorafenib and nivolumab combination (RegoNivo) improves overall survival compared with current standard chemotherapy options in refractory AGOC.
Phase 3 • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can sex boost the odds of IVF success?
Knowledge-focused Stopped earlyThis study aims to evaluate the impact of sexual intercourse and orgasm in the 72 hrs following embryo transfer of blastocysts on the clinical pregnancy rate. An impact on sexual activity and a decrease in the frequency of intercourse has been observed in infertile couples. In c…
Sponsor: Fundación Santiago Dexeus Font • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New combo targets advanced prostate cancer in phase 2 trial
Disease control Recruiting nowThis phase II trial studies the effect of talazoparib with androgen deprivation therapy and abiraterone in treating castration sensitive prostate cancer patients. Talazoparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged.…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cough medicine repurposed to fight dementia with lewy bodies
Disease control Recruiting nowThis is a confirmatory investigational medicinal product (IMP) study to investigate the effects on cognition, functional decline and on neuropsychiatric symptoms of the Glucocerebrosidase (GCase) enhancing chaperone ambroxol in participants diagnosed with prodromal and early deme…
Phase 2 • Sponsor: Helse Fonna • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New heart valve implant aims to fix leaky mitral valve without open surgery
Disease control OngoingTo evaluate the safety and performance of the Tendyne™ Mitral Valve System when used as intended in a contemporary, real-world setting.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for kids with rare cancers: targeted drug selpercatinib tested in phase 2 trial
Disease control OngoingThis phase II pediatric MATCH treatment trial studies how well selpercatinib works in treating patients with solid tumors that may have spread from where they first started to nearby tissue, lymph nodes, or distant parts of the body (advanced), lymphomas, or histiocytic disorders…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
One shot may be enough: HPV vaccine study could change guidelines
Prevention OngoingThis study aims to evaluate the vaccine effectiveness of 1 dose the nonavalent human papillomavirus (HPV) vaccine against HPV16, 18, 31, 33, 45, 52, and 58 infection among young adult women in Sweden participating in a nationwide HPV elimination trial.
Phase 4 • Sponsor: Karolinska Institutet • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
Twice-Yearly drug could beat river blindness
Disease control OngoingThe primary purpose of this phase 3b study is to determine the safety and efficacy of moxidectin administration twice a year, compared to once a year, in maintaining undetectable levels in skin of O. volvulus microfilaria in skin, the parasite that causes river blindness. Second…
Phase 3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
A tablet tool may empower women to prevent HIV — trial puts it to the test
Prevention CompletedTo address the significant barriers to PrEP implementation for those who were assigned female at birth and self-identify as a woman and address racial inequities in HIV prevention in the United States (US), a novel approach that accounts for multilevel influences is necessary. Th…
Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
New drug moxidectin put to the test against river blindness in massive safety trial
Disease control CompletedThe purpose of this phase 3b study is to determine the safety of a single dose of moxidectin, compared to a single dose of ivermectin, in individuals living in onchocerciasis endemic areas and in individuals living in onchocerciasis endemic areas with high levels of lymphatic fil…
Phase 3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
Disease control Stopped earlyThis is an open-label, multi-center, phase I study designed to assess the maximum tolerated dose of ribociclib and belinostat in combination. The trial will open with a dose escalation followed by an expansion cohort at the identified dose. Dose escalation will be open to the enr…
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC